Ovarian Cancer: Obese and non-obese patients have same overall survival

A new study showed that when actual body weight was used in chemo dosing for epithelial ovarian cancer, the overall survival is 40 months for non-obese patients and 47 months for obese patients, not a significant difference. Similar outcomes are seen in obese and non-obese cancer survivors being monitored for recurrence of their ovarian cancer, the study authors said. Earlier studies found obesity as a negative indicator.

Read the whole article on Science Daily

More from Science Daily